Advertisement
Also will assess ability of high-intensity exercise to offset the cognitive decline
Study reveals viable alternative for patients with refractory disease
Maintaining patients' home medication regimens looms large, study suggests
Consortium is uncovering risk factors that spur disease development in an understudied group
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Criteria-based diagnosis of traumatic encephalopathy syndrome predicts changes in brain volumes and cognition
Risk of new MS activity is small in those older than 55 with stable disease who stop MS therapy
Insights from 15 years of experience of Cleveland Clinic’s spine tumor board
Two-year trial results find Total Posterior Spine System to be safe and effective
Growing public interest in hallucinogens highlights their therapeutic promise and potential perils
Minimally invasive approach is gaining prominence as a fast and safe outpatient procedure
Advertisement
Advertisement